Core A: Islet Cell Biology Core

核心 A:胰岛细胞生物学核心

基本信息

  • 批准号:
    8626377
  • 负责人:
  • 金额:
    $ 18.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-02-01 至 2018-01-31
  • 项目状态:
    已结题

项目摘要

The Islet Cell Biology Core provides services and hands-on training to independently funded investigators in the isolation and functional characterization of pancreatic islets from normal and diabetic humans and mice. It also maintains a repository of insulinoma cell lines as well as other endocrine cell lines. The primary emphasis of the Core is to facilitate studies of primary islet cells, and it has developed many unique tools and techniques for carrying such studies including novel animals models, biophysical methods and a library of adenovirus-based expression constructs for studying beta-cell function. The long-range objectives and goals of the Islet Cell Biology Core are to provide state-of-the-art technology and know-how to understanding the beta cell in health and disease. It has the following Specific Aims and Objectives: Provide advice, service and training in the isolation of pancreatic islets from normal and diabetic mice and humans; Provide insulinoma and other endocrine cell lines; Provide advice, service and training in the characterization of mouse and human pancreatic islets and beta cell (insulin biosynthesis and secretion; biophysical methods for studying islet and beta-cell function (e.g. calcium imaging, electrophysiology, total internal reflection fluorescent microscopy); biochemical methods for studying beta-cell function (e.g. phosphorylation, proliferation, apoptosis); and immunohistochemical analysis of pancreatic islets) and Provide advice, service and training on the use of adenovirus-based expression constructs to study protein function in beta cells and other cell types in vitro and in vivo. Drs. Philipson, Rhodes and Witkowski are Directors of this Core. They will be advised by experts in pancreatic islets and beta cells (Prince and Steiner), cellular and physiological imaging (Bindokas, Chen and Glick), ion channels (Hanck and Nelson), spectroscopy (Halpern and Scherer) and cell dynamics (Dinner) to ensure that the Core services are at the forefront of technology and thus able to anticipate and quickly repond to users needs.
胰岛细胞生物学核心为独立资助的研究人员提供正常和糖尿病人类和小鼠胰岛的分离和功能表征方面的服务和实践培训。它还维护胰岛素瘤细胞系以及其他内分泌细胞系的储存库。核心的主要重点是促进原代胰岛细胞的研究,它开发了许多独特的工具和技术来进行此类研究,包括新颖的动物模型、生物物理方法和用于研究β细胞功能的基于腺病毒的表达构建体库。胰岛细胞生物学核心的长期目标是提供最先进的技术和专业知识来了解健康和疾病中的 β 细胞。它有以下具体目的和目标: 提供从正常和糖尿病小鼠和人类中分离胰岛的建议、服务和培训;提供胰岛素瘤等内分泌细胞系;提供小鼠和人类胰岛和β细胞表征的建议、服务和培训(胰岛素生物合成和分泌;研究胰岛和β细胞功能的生物物理方法(例如钙成像、电生理学、全内反射荧光显微镜);研究β细胞功能的生物化学方法(例如磷酸化、增殖、 细胞凋亡);和胰岛的免疫组织化学分析)并提供有关使用基于腺病毒的表达构建体在体外和体内研究β细胞和其他细胞类型的蛋白质功能的建议、服务和培训。博士。 Philipson、Rhodes 和 Witkowski 是该核心的董事。他们将得到胰岛和β细胞(Prince和Steiner)、细胞和生理成像(Bindokas、Chen和Glick)、离子通道(Hanck和Nelson)、光谱学(Halpern和Scherer)和细胞动力学(Dinner)专家的建议,以确保核心服务处于技术前沿,从而能够预测并快速响应用户需求。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Louis H. Philipson其他文献

Ion Channels, Action Potentials and Ca<sup>2+</sup> Handling in Human Pancreatic Beta-Cells. a Computational Approach
  • DOI:
    10.1016/j.bpj.2010.12.696
  • 发表时间:
    2011-02-02
  • 期刊:
  • 影响因子:
  • 作者:
    Leonid E. Fridlyand;Louis H. Philipson
  • 通讯作者:
    Louis H. Philipson
An online monogenic diabetes discussion group: supporting families and fueling new research
  • DOI:
    10.1016/j.trsl.2015.06.013
  • 发表时间:
    2015-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Marie E. Perrone;David Carmody;Louis H. Philipson;Siri Atma W. Greeley
  • 通讯作者:
    Siri Atma W. Greeley
The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis
  • DOI:
    10.1007/s11606-021-07105-9
  • 发表时间:
    2021-09-10
  • 期刊:
  • 影响因子:
    4.200
  • 作者:
    Jason T. Alexander;Erin M. Staab;Wen Wan;Melissa Franco;Alexandra Knitter;M. Reza Skandari;Shari Bolen;Nisa M. Maruthur;Elbert S. Huang;Louis H. Philipson;Aaron N. Winn;Celeste C. Thomas;Meltem Zeytinoglu;Valerie G. Press;Elizabeth L. Tung;Kathryn Gunter;Brittany Bindon;Sanjay Jumani;Neda Laiteerapong
  • 通讯作者:
    Neda Laiteerapong
The Two-Pore-Domain Potassium Channels, TASK-1 and TASK-3, regulate Pancreatic Beta-Cell Membrane Potential in Response to pH and Anesthetics
  • DOI:
    10.1016/j.bpj.2010.12.743
  • 发表时间:
    2011-02-02
  • 期刊:
  • 影响因子:
  • 作者:
    Prasanna Dadi;Louis H. Philipson;David A. Jacobson
  • 通讯作者:
    David A. Jacobson
Dynamin Function in Exocytosis and Endocytosis Coupling of Dense-Core Vesicles in Pancreatic Beta Cells
  • DOI:
    10.1016/j.bpj.2019.11.2700
  • 发表时间:
    2020-02-07
  • 期刊:
  • 影响因子:
  • 作者:
    Fan Fan;Jenifer Wendlick;Natalia Tamarina;Yumei Wu;Shawn Ferguson;Louis H. Philipson;Pietro De Camilli;Xuelin Lou
  • 通讯作者:
    Xuelin Lou

Louis H. Philipson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Louis H. Philipson', 18)}}的其他基金

Center for Identification and Study of Individuals with Atypical Diabetes Mellitus
非典型糖尿病个体识别和研究中心
  • 批准号:
    10660917
  • 财政年份:
    2018
  • 资助金额:
    $ 18.78万
  • 项目类别:
Chicagoland Diabetes TrialNet Clinical Center
芝加哥糖尿病 TrialNet 临床中心
  • 批准号:
    9414298
  • 财政年份:
    2014
  • 资助金额:
    $ 18.78万
  • 项目类别:
Chicagoland Diabetes TrialNet Clinical Center
芝加哥糖尿病 TrialNet 临床中心
  • 批准号:
    9065721
  • 财政年份:
    2014
  • 资助金额:
    $ 18.78万
  • 项目类别:
Chicagoland Diabetes TrialNet Clinical Center
芝加哥糖尿病 TrialNet 临床中心
  • 批准号:
    8774722
  • 财政年份:
    2014
  • 资助金额:
    $ 18.78万
  • 项目类别:
Core A: Islet Cell Biology Core
核心 A:胰岛细胞生物学核心
  • 批准号:
    8446544
  • 财政年份:
    2013
  • 资助金额:
    $ 18.78万
  • 项目类别:
K+ Channel Expression in Pancreatic Beta-Cells
胰腺 β 细胞中 K 通道的表达
  • 批准号:
    8006768
  • 财政年份:
    2010
  • 资助金额:
    $ 18.78万
  • 项目类别:
Diabetes Research and Training Center
糖尿病研究与培训中心
  • 批准号:
    7500638
  • 财政年份:
    2006
  • 资助金额:
    $ 18.78万
  • 项目类别:
ISLET CELL BIOLOGY CORE
胰岛细胞生物学核心
  • 批准号:
    7660174
  • 财政年份:
    2005
  • 资助金额:
    $ 18.78万
  • 项目类别:
INSULIN SECREETION IN ISLET CELL TRANSPLANT RECIPIENTS
胰岛细胞移植受者的胰岛素分泌
  • 批准号:
    7201053
  • 财政年份:
    2005
  • 资助金额:
    $ 18.78万
  • 项目类别:
Pediatric Endocrinology Research Training Grant
儿科内分泌学研究培训补助金
  • 批准号:
    8867222
  • 财政年份:
    2004
  • 资助金额:
    $ 18.78万
  • 项目类别:

相似海外基金

cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
  • 批准号:
    10436626
  • 财政年份:
    2021
  • 资助金额:
    $ 18.78万
  • 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10557162
  • 财政年份:
    2021
  • 资助金额:
    $ 18.78万
  • 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
  • 批准号:
    21K08199
  • 财政年份:
    2021
  • 资助金额:
    $ 18.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10330464
  • 财政年份:
    2021
  • 资助金额:
    $ 18.78万
  • 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
  • 批准号:
    9807741
  • 财政年份:
    2019
  • 资助金额:
    $ 18.78万
  • 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2018
  • 资助金额:
    $ 18.78万
  • 项目类别:
    Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
  • 批准号:
    18K15937
  • 财政年份:
    2018
  • 资助金额:
    $ 18.78万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2017
  • 资助金额:
    $ 18.78万
  • 项目类别:
    Discovery Grants Program - Individual
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
  • 批准号:
    1813152
  • 财政年份:
    2016
  • 资助金额:
    $ 18.78万
  • 项目类别:
    Studentship
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
  • 批准号:
    16K09118
  • 财政年份:
    2016
  • 资助金额:
    $ 18.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了